Table 4 Univariate logistic regression analysis of MRI findings and effect of neoadjuvant chemotherapy
Variable | Univariate analysis | ||
|---|---|---|---|
OR | 95% CI | P value | |
Breast type | |||
Fibrous gland | 0.682 | 0.085–5.448 | 0.718 |
Compact | 0.795 | 0.125–5.045 | 0.808 |
Unknown | Ref | ||
Lesion types | |||
Irregular | 0.182 | 0.027–1.243 | 0.082 |
Section distribution | Ref | ||
Circular | 0.600 | 0.070–5.136 | 0.641 |
Satellite lesions | 0.250 | 0.027–2.319 | 0.223 |
Lesion location | |||
Left | 0.217 | 0.051–0.936 | 0.040 |
Right | Ref | ||
Lesion quadrant | |||
Outer quadrant | 0.182 | 0.027–1.243 | 0.082 |
Upper inner | 0.600 | 0.070–5.136 | 0.641 |
Central | Ref | ||
Diffuse | 0.250 | 0.027–2.319 | 0.223 |
BI-RADS rating | |||
5 | 1.667 | 0.306–9.080 | 0.555 |
6 | Ref | ||
Unknown | 5.000 | 0.212–117.894 | 0.318 |
Pectoral muscle invasive | |||
Yes | 2.037 | 0.383–10.845 | 0.404 |
No | Ref | ||
Skin around areola invasive | |||
Yes | 2.692 | 0.713–10.170 | 0.144 |
No | Ref | ||
Crater nipple | |||
Yes | 3.636 | 0.699–18.918 | 0.125 |
No | Ref | ||
Internal mammary artery thickening | |||
Yes | 1.095 | 0.293–4.097 | 0.892 |
No | Ref | ||
Subareolar duct invasive | |||
Yes | 3.636 | 0.699–18.918 | 0.125 |
No | Ref | ||
Contralateral breast | |||
Hyperplasia and adenosis | 6.158 | 0.694–54.644 | 0.103 |
Galactocele/fortified nodule | Ref | ||
No | 4.333 | 0.326–57.649 | 0.267 |
Standard ADC change* | |||
≤ 15% | 9.9 | 1.16–84.471 | 0.036 |
> 15% | Ref | ||
Tumor size change* | |||
≤ 15% | 0.156 | 0.018–1.339 | 0.090 |
> 15% | Ref | ||
Slow ADC change* | |||
≤ 15% | 3.75 | 0.714–19.707 | 0.118 |
> 15% | Ref | ||
TIC ype | |||
Ascending | 0.400 | 0.036–4.411 | 0.454 |
Reduced | Ref | ||
Invariable | 0.522 | 0.129–2.116 | 0.362 |